Search for: "Abbott et al v. Pfizer Inc"
Results 1 - 20
of 36
Sorted by Relevance
|
Sort by Date
11 Sep 2009, 10:33 am
Parke-Davis, Division of Warner-Lambert/Pfizer Thomas Cona et. al. v. [read post]
17 Feb 2010, 8:00 am
(patent infringement) 1/15: Pfizer Inc., Pharmacia Corp., Pharmacia & Upjohn Co., Pharmacia & Upjohn LLC, Pharmacia & Upjohn Company LLC, et al. v. [read post]
1 Feb 2012, 11:15 am
Abbott Laboratories, et al., No. 2:10-cv-03242 (E.D. [read post]
1 Dec 2009, 9:45 am
Ltd., Nintendo of America Inc., Sony Corporation, Sony Computer Entertainment Inc., Sony Computer Entertainment America, Inc., et al. [read post]
28 Jul 2010, 12:06 am
Abbott Laboratories Inc. et al. [read post]
23 Jun 2010, 10:28 pm
(Patent Docs) (Patent Docs) Sutent (Sunitinib) - US: Patent infringement complaint following a Para IV certification: Pfizer Inc. et al. v. [read post]
5 May 2010, 4:46 am
-Florida et al.; and Abbott Laboratories et al. v. [read post]
15 Jun 2011, 4:56 am
(Patent Docs) Detrol LA (Tolterodine) – US: Patent infringement complaint filed in response to Para IV certification: Pfizer, Inc. et al. v. [read post]
24 Mar 2010, 4:45 am
INPI (EPLAW) Lyrica (Pregabalin) – US: Patent infringement complaint filed following a Para IV certification: Pfizer Inc. et al. v. [read post]
10 Feb 2010, 4:47 pm
Sepracor Inc (EPLAW) Zyvox (Linezolid) – US: Patent infringement complaint filed following a Paragraph IV certification: Pfizer Inc. et al. v. [read post]
29 Jun 2010, 6:01 pm
(Patent Docs) Sutent (Sunitinib) – US: Patent infringement complaint filed following a Paragraph IV certification: Pfizer Inc. et al. v. [read post]
30 Jun 2010, 5:52 am
(Patent Docs) Sutent (Sunitinib) – US: Patent infringement complaint filed following a Paragraph IV certification: Pfizer Inc. et al. v. [read post]
13 May 2010, 4:58 pm
Pfizer, Inc. et al. [read post]
10 Mar 2010, 5:22 am
KG et al. v. [read post]
10 Mar 2010, 5:22 am
KG et al. v. [read post]
18 Mar 2010, 2:30 am
Teva Pharmaceuticals USA, Inc. et al. and Gilead Sciences, Inc., et al. v. [read post]
2 Dec 2009, 4:31 am
Because other countries just decide to pay less – Pfizer’s patent battle against UniLab (Patent Baristas) Moxifloxacin – Venezuela annuls two of Bayer’s patents relating to Moxifloxacin (IP tango) (IP tango) Plavix (Clopidogrel) – India: Indian company, Cadila, bears the brunt of section 3(d) (Spicy IP) Sanctura (Trospium) – US: Allergan files patent infringement suit against Sandoz in response to Para IV challenge (Patent Docs) Taxotere (Docetaxel)… [read post]
7 Sep 2010, 6:10 pm
Genpharm Inc. et al. [read post]
24 Aug 2011, 12:33 am
The lobbying push for a PTE (FDA Law Blog) US: Generics fees: A fantastic opportunity (profitability through simplicity) USPTO announces agenda for next BCP customer partnership meeting (Patent Docs) US: GOP candidates unified in opposition to embryonic cell research (Patent Docs) US: District Court Massachusetts: Method of detecting fetal down syndrome passes muster under Bilski‘s machine-or-transformation test: PerkinElmer, Inc., et. al. v. [read post]
9 Sep 2009, 7:14 am
(America-Israel Patent Law) Avinza (Morphine) – US: King Pharmaceuticals, Elan files patent infringement suit against Sandoz in response to Para IV challenge (Patent Docs) Cipro (Ciprofloxacin) – US: California court rules that Bayer AG et al did not violate state antitrust law in Cipro reverse payment case (FDA Law Blog) Effexor (Venlafaxine) - Israel: Patent oppositions: should substance or procedural issues win out? [read post]
